Nurse-Provided Education Crucial to Sural Nerve Graft Prostatectomy Patients

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 12
Volume 10
Issue 12

SAN DIEGO--Sural nerve grafting is a new procedure that may allow prostate patients undergoing radical prostatectomy to maintain sexual potency. With limited information currently available about the procedure, the ambulatory nurse’s role in educating these patients can be critical in alleviating anxiety and stress, said Mary Schoen, RN, MSN, MPH, a clinical nurse in Memorial Sloan-Kettering Cancer Center’s Urology Department.

SAN DIEGO--Sural nerve grafting is a new procedure that may allow prostate patients undergoing radical prostatectomy to maintain sexual potency. With limited information currently available about the procedure, the ambulatory nurse’s role in educating these patients can be critical in alleviating anxiety and stress, said Mary Schoen, RN, MSN, MPH, a clinical nurse in Memorial Sloan-Kettering Cancer Center’s Urology Department.

Ms. Schoen and her colleague, Dominique DePalma, RN, MA, OCN, also a clinical nurse in the Urology Department, discussed the importance of providing support and education to this population at the 26th Annual Conference of the Oncology Nursing Society (abstract 72).

If tumor invasion into the neurovascular bundle branches is detected during surgery, the nerves allowing erectile function must be resected.

"For men unable to have nerve-sparing surgery, the surgeon will perform a sural nerve graft, taking a nerve from around the ankle bone and placing it around the prostate," Ms. Schoen said. Sural nerve graft patients are expected to regain erectile function within 14 to 18 months after the surgery.

Patients are extremely nervous prior to the surgery and even after surgery, the nurses said. "We get a lot of phone calls. They need a great deal of support," Ms. Schoen said. "Our job is to provide patient education, do referrals to erectile dysfunction specialists, start them on Viagra, and just reassure them." Ms. DePalma noted that the men who have the surgery have more advanced cancer than other patients, so they may need more education and support.

Said Ms. Schoen: "We’re educating other nurses about this new procedure so that they, in turn, can help alleviate patient concerns and make the appropriate referrals." 

Recent Videos
A phase 1 trial assessed the use of PSCA-directed CAR T cells in patients with metastatic castration-resistant prostate cancer.
Findings from a phase 1 study may inform future trial designs intended to yield longer responses with PSCA-targeted CAR T cells.
A phase 1 trial assessed the use of PSCA-directed CAR T cells in patients with metastatic castration-resistant prostate cancer.
Two women in genitourinary oncology discuss their experiences with figuring out when to begin a family and how to prioritize both work and children.
Over the past few decades, the prostate cancer space has evolved with increased funding for clinical trial creation and enrollment.
Rohit Gosain, MD; Rahul Gosain, MD; and Rana R. McKay, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Rana R. McKay, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Rana R. McKay, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Rana R. McKay, MD, presenting slides
Anemia in patients who receive talazoparib plus enzalutamide for metastatic castration-resistant prostate cancer appears to be manageable without any compromises in patient-reported outcomes and quality of life.
Related Content